Literature DB >> 15275541

Human resistance to Schistosoma infections: age or experience?

B Gryseels1.   

Abstract

Entities:  

Year:  1994        PMID： 15275541     DOI： 10.1016/0169-4758(94)90226-7

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


× No keyword cloud information.
  11 in total

1.  Gender-dependent specific immune response during chronic human Schistosomiasis haematobia.

Authors:  F Remoué; D To Van; A M Schacht; M Picquet; O Garraud; J Vercruysse; A Ly; A Capron; G Riveau
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Human schistosomiasis haematobium: effective diagnosis of active infection using a pair of monoclonal antibodies against soluble egg antigen.

Authors:  F Salah; A El Bassiouny; I Rabia; Z Demerdash; M Roshdy; Z Shaker
Journal:  Parasitol Res       Date:  2006-04-22       Impact factor: 2.289

3.  Inbreeding within human Schistosoma mansoni: do host-specific factors shape the genetic composition of parasite populations?

Authors:  F Van den Broeck; L Meurs; J A M Raeymaekers; N Boon; T N Dieye; F A M Volckaert; K Polman; T Huyse
Journal:  Heredity (Edinb)       Date:  2014-03-12       Impact factor: 3.821

4.  Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy.

Authors:  R El Ridi; C B Shoemaker; F Farouk; N H El Sherif; A Afifi
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Juvenile rhesus monkeys have more colonic granulomas than adults after primary infection with Schistosoma mansoni.

Authors:  Johannes J P M Bogers; Shyama Chatterjee; Werner Jacobs; Padraic G Fallon; David W Dunne; Jan A M Langermans; Andre M Deelder; Alan W Thomas; Eric A E Van Marck
Journal:  Virchows Arch       Date:  2004-07-30       Impact factor: 4.064

6.  Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.

Authors:  Francisca Mutapi; Nadine Rujeni; Claire Bourke; Kate Mitchell; Laura Appleby; Norman Nausch; Nicholas Midzi; Takafira Mduluza
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

7.  IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.

Authors:  Mark S Wilson; Allen W Cheever; Sandra D White; Robert W Thompson; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

8.  Intestinal schistosomiasis and geohelminths of Ukara Island, North-Western Tanzania: prevalence, intensity of infection and associated risk factors among school children.

Authors:  Moshi Mugono; Evelyne Konje; Susan Kuhn; Filbert J Mpogoro; Domenica Morona; Humphrey D Mazigo
Journal:  Parasit Vectors       Date:  2014-12-23       Impact factor: 3.876

9.  Evidence of long term benefit of morbidity reduction due to praziquantel treatment against schistosoma mansoni in kigungu fishing village in entebbe, Uganda.

Authors:  Emmanuel I Odongo-Aginya; Fk Kironde; Mi Lyazi; Harman Sempewo; Rodrigo Correa Oliveira
Journal:  Afr J Infect Dis       Date:  2011

10.  A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community is required for association with highly prevalent organ related morbidity.

Authors:  Edridah M Tukahebwa; Pascal Magnussen; Henry Madsen; Narcis B Kabatereine; Fred Nuwaha; Shona Wilson; Birgitte J Vennervald
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.